Table 5.

Activity of antimicrobial agents tested against 1922 Escherichia isolates from intra-abdominal infections.

Activity of antimicrobial agents tested against 1922 Escherichia isolates from intra-abdominal infections in the SENTRY program collected during 2019, 2020, and 2021
Organisms include: Escherichia coli (1921), E. marmotae (1)
Antimicrobial Agent	Continent	Count	MIC50	MIC90	Range	CLSI			EUCAST
						S (%)	I (%)	R (%)	S (%)	I (%)	R (%)
Ertapenem	All	1459	≤0.008	0.03	≤0.008 to >2	98.5	0.5	1.0	98.5	0	1.5
	Asia-W. Pacific	209	≤0.008	0.06	≤0.008 to >2	96.7	1.0	2.4	96.7	0	3.3
	Europe	510	≤0.008	0.03	≤0.008 to >2	99.0	0.8	0.2	99.0	0	1.0
	Latin America	178	≤0.008	0.06	≤0.008 to >2	99.4	0.0	0.6	99.4	0	0.6
	North America	562	≤0.008	0.03	≤0.008 to >2	98.4	0.4	1.2	98.4	0	1.6
Imipenem	All	1922	≤0.12	≤0.12	≤0.12 to >8	99.2	0.2	0.7	99.3	0.2	0.5
	Asia-W. Pacific	336	≤0.12	0.25	≤0.12 to >8	98.2	0.0	1.8	98.2	0.0	1.8
	Europe	775	≤0.12	≤0.12	≤0.12 to 4	99.6	0.3	0.1	99.9	0.1	0.0
	Latin America	249	≤0.12	0.25	≤0.12 to 8	98.4	0.0	1.6	98.4	0.8	0.8
	North America	562	≤0.12	≤0.12	≤0.12 to >8	99.5	0.2	0.4	99.6	0.0	0.4
Meropenem	All	1922	≤0.015	0.03	≤0.015 to >32	99.3	0.2	0.6	99.4	0.2	0.4
	Asia-W. Pacific	336	≤0.015	0.03	≤0.015 to >32	98.2	0.0	1.8	98.2	0.6	1.2
	Europe	775	≤0.015	0.03	≤0.015 to 16	99.9	0.0	0.1	99.9	0.0	0.1
	Latin America	249	≤0.015	0.03	≤0.015 to 32	98.4	0.8	0.8	99.2	0.0	0.8
	North America	562	≤0.015	0.03	≤0.015 to >32	99.5	0.2	0.4	99.6	0.2	0.2

Abbreviations (MIC50 and MIC90: the lowest concentration of the antibiotic at which 50 and 90% of the isolates were inhibited; CLSI: Clinical and Laboratory Standards Institute; EUCAST: European Committee on Antimicrobial Susceptibility Testing; S (%) percentage of susceptible pathogens, evidenced in green; I (%) percentace of pathogens with intermediate susceptibility, evidenced in yellow; R (%) percentage of resistant pathogens, evidenced in red).